INESS considers it premature to support the use of colchicine for COVID-19The Ordre des pharmaciens du Québec has instructed members not to dispense colchicine which would be prescribed as a preventive measure for a possible diagnosis of COVID-19. Medical cannabis may have role in decreasing opioid use: studyStudy shows medical cannabis use may help decrease the use of prescription medications including opioids, and may have a harm-reduction role in the opioid crisis. Investigations over into hospital doctors who jumped queues for second COVID-19 shots Time for a change? Colchicine under consideration by Health Canada as a COVID-19 treatment Quebec study suggests colchicine may reduce death or hospitalization in outpatients with COVID-19. Edmonton pharmacist pays for medications of patients in need Also counsels patients on government funding programs Home-based electronic medication dispensing improves adherence An in-home electronic medication dispensing device improves medication adherence among older adults. McGill launches study to examine if an antidepressant slows the progression of COVID-19 ISMP Canada advocates for standardization of calcium content on product labels Confusion over strength labelled as elemental calcium or calcium salt has led to cases of serious unintentional overdose. New curriculum for Canadian medical students addresses the opioid crisis First Previous 369 370 371 372 373 Next Last
